Here is a 200-word summary of the case:
Mankind Pharma Ltd. (Mankind) filed a lawsuit against Sepkind Pharma Pvt. Ltd. (Sepkind) seeking a permanent injunction to stop the infringement of its trade mark “MANKIND”, copyright, and passing off. The Delhi High Court granted an ex-parte ad-interim injunction to Mankind, restraining Sepkind from using the impugned trade mark “SEPKIND” or any other mark similar to Mankind’s. Mankind claimed that it had been using the mark “MANKIND” since 1986 and had registered it in various classes under the Nice Classification. Sepkind’s use of the mark “SEPKIND” with a similar logo and tagline was deceptively similar to Mankind’s. The court found that Mankind had demonstrated a prima facie case for an injunction and that Sepkind would suffer irreparable loss if one was not granted. The court also appointed local commissioners to seize and inventory infringing products and materials. The court directed both parties to comply with further directions related to the appointment of local commissioners. The case was listed for further hearing on April 16, 2025.